Benzinga | Jul 31, 2020 06:39AM EDT

IDEXX Laboratories Q2 EPS $1.72 Beats $1.16 Estimate, Sales $637.59M Beat $589.98M Estimate

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $1.72 per share which beat the analyst consensus estimate of $1.16 by 48.28 percent. This is a 20.28 percent increase over earnings of $1.43 per share from the same period last year. The company reported quarterly sales of $637.59 million which beat the analyst consensus estimate of $589.98 million by 8.07 percent. This is a 2.82 percent increase over sales of $620.10 million the same period last year.